CA
TMDX icon

Cetera Advisors’s Transmedics TMDX Stock Holding History

Cetera Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$392K Buy
+5,302
New +$437K ﹤0.01% 1764

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cetera Advisors's TMDX Position: Q1 2024 in Review

Cetera Advisors opened a new position in Transmedics (TMDX) in Q1 2024: 5,302 shares worth $392K. The stake represents ﹤0.01% of the portfolio and ranks #1764 among its holdings.

263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

  • Cetera Advisors held 5,302 shares of Transmedics worth $392K as of Q1 2024.
  • Transmedics was a new Cetera Advisors position in Q1 2024.
  • Transmedics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1764 holding.
  • 263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.